GENEVA, Sept. 18 -- EMOVIAR PHARMACON GMBH filed a patent application (EP2026/054707) for “HIGH DOSAGE SUSTAINED RELEASE FORMS FOR LOW SOLUBILITY COMPOUNDS AND METHODS FOR PREPARING THESE”. With publication no. WO/2026/185017, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 9/50
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....